ZEKE CAPITAL ADVISORS, LLC – Alnylam Pharmaceuticals, Inc. Transaction History
ZEKE CAPITAL ADVISORS, LLC portfolio value:
$2.86M
portfolio value
ZEKE CAPITAL ADVISORS, LLC quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 777K | $200.16 | 14.29K | |
| Q2 2022 | share | Decrease | -8.57% | -1.33K shares | -469K | $145.85 | 14.29K |
| Q1 2022 | share | Increase | +8.90% | 1.27K shares | 119K | $163.29 | 15.63K |
| Q4 2021 | share | Increase | +9.74% | 1.27K shares | -36K | $171.03 | 14.35K |
| Q3 2021 | share | 0.00% | 0 shares | 253K | $188.81 | 13.08K | |
| Q2 2021 | share | Increase | 0.00% | 13.08K shares | 2.21M | $169.52 | 13.08K |
| Q1 2020 | share | Decrease | -100.00% | -5.30K shares | -611K | $108.85 | 0 |
| Q4 2019 | share | Decrease | -19.19% | -1.26K shares | 83K | $115.17 | 5.30K |
| Q3 2019 | share | Decrease | -17.96% | -1.43K shares | -53K | $80.42 | 6.57K |
| Q2 2019 | share | Increase | +10.08% | 733 shares | -99K | $72.56 | 8.00K |
| Q1 2019 | share | Decrease | -25.03% | -2.42K shares | -28K | $93.45 | 7.27K |
| Q4 2018 | share | Increase | +31.97% | 2.35K shares | 64K | $72.91 | 9.70K |
| Q3 2018 | share | Increase | 0.00% | 7.35K shares | 644K | $87.52 | 7.35K |